Company News, Financial News

Valeant To Acquire Obagi

Author Image

By: TOM BRANNA

Editor

• Valeant Pharmaceuticals International Inc. has entered into an agreement to acquire Obagi Medical Products Inc. According to reports, Valeant will acquire all the outstanding common stock of Obagi for $19.75 a share in cash, or $360 million. The professional skin care company was founded by Beverly Hills-based dermatologist Zein Obagi in 1988. The Obagi brand is only available through medical professionals. Dr. Obagi sold his controlling interest to outside investors in 1997. At press time, ...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters